Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro, JJ. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro, JJ
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial Fibrillation prevalence increase from 1992 to 2002
    Among Medicare patients ages 65 and older, atrial fibrillation prevalence increased from 3.2% in 1992 to 6.0% in 2002–with higher prevalence in older patients.  
  • The risk of stroke attributable to atrial fibrillation by age
    The risk of stroke attributable to atrial fibrillation increases from 1.5% for those ages 50 to 59 to 23.5% for those ages 80 to 89.  
  • Annual AFib care
    Each year AFib leads to around 350,000 hospitalizations, 5 million office visits, 276,000 emergency department visits, and 234,000 hospital outpatient department visits.  
  • Atrial fibrillation costs
    Around 73% of total U.S. atrial fibrillation costs are for inpatient expenses.  
  • Annual direct cost of Afib
    Average annual cost comparison between patients with and without atrial fibrillation